Leica Biosystems - Cellular Pathology - MSC

The procurement process overseen by the Norfolk and Norwich University Hospitals NHS Foundation Trust for the project titled "Leica Biosystems - Cellular Pathology - MSC" has reached the award stage. This contract involves pathology services and falls under the industry category of pathology services, located in the East of England, United Kingdom. The contracting process used a selective procurement method, specifically a call-off from a framework agreement.

The tender process concluded on 17th April 2025, and the contract period spans from 1st June 2025 to 31st May 2032. The contract, valued at £8,970,168.32, has been awarded to LEICA MICROSYSTEMS (UK) LIMITED. This tender presents significant opportunities for businesses specialising in cellular pathology, particularly those with capabilities in immunohistochemistry, molecular diagnostics, and histology tissue processing.

Although it was suitable for larger organisations rather than SMEs or VCSEs, businesses within the pathology and medical equipment sectors would have found themselves well-positioned to compete, given the specific requirements of pathology services such as tissue staining, scanning, and the provision of specialised machinery. The procurement process's selective nature ensures that only highly capable and experienced suppliers, like LEICA MICROSYSTEMS, are considered, underscoring the importance of expertise and resource capability for prospective bidders in similar future opportunities.